Literature DB >> 21118937

Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.

Pieter-Paul van Thiel1, Tjalling Leenstra, Henry J de Vries, Allard van der Sluis, Tom van Gool, Alex C Krull, Michèle van Vugt, Peter J de Vries, Jimmy E Zeegelaar, Aldert Bart, Wendy F van der Meide, Henk D F H Schallig, William R Faber, Piet A Kager.   

Abstract

Cutaneous leishmaniasis caused by Leishmania major infection affected 172 (18.3%) of 938 Dutch military troops deployed in northern Afghanistan in 2005. The high attack rate was a result of initial insufficient availability of means of prevention and insufficient adherence to preventive measures. At presentation, the lymphatic system was involved in 24.8%. Treatment with intralesional injections of antimony with or without cryotherapy was satisfactory, but 19.5% of patients received secondary treatment with miltefosine. Six months after treatment, 128 (77.1%) of 166 treated patients were cured, 16 (9.6%) were lost to follow-up, and 22 (13.3%) already experienced cure at six weeks but were not seen at six months. Natural evolution played a role in this observational study, which showed cure of all patients seen at six months. In general, management of cutaneous leishmaniasis was feasible under field conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118937      PMCID: PMC2990047          DOI: 10.4269/ajtmh.2010.10-0143

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  War and gerbils compound Afghan leishmaniasis epidemic.

Authors:  Khabir Ahmad
Journal:  Lancet Infect Dis       Date:  2002-05       Impact factor: 25.071

2.  Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples.

Authors:  Wendy F van der Meide; Gerard J Schoone; William R Faber; Jim E Zeegelaar; Henry J C de Vries; Yusuf Ozbel; Rudy F M Lai A Fat; Leíla I A R C Coelho; Masoom Kassi; Henk D F H Schallig
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Estimating incubation period with multiple contact days.

Authors:  Wilson Ws Tam; Tze Wai Wong
Journal:  Scand J Infect Dis       Date:  2007

4.  Genetic and biological diversity among populations of Leishmania major from Central Asia, the Middle East and Africa.

Authors:  Mustafa Elfari; Lionel F Schnur; Margarita V Strelkova; Carol L Eisenberger; Raymond L Jacobson; Charles L Greenblatt; Wolfgang Presber; Gabriele Schönian
Journal:  Microbes Infect       Date:  2004-11-30       Impact factor: 2.700

5.  Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan.

Authors:  P P A M van Thiel; T Leenstra; P A Kager; H J de Vries; M van Vugt; W F van der Meide; A Bart; J E Zeegelaar; A van der Sluis; H D F H Schallig; T van Gool; W R Faber; P J de Vries
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

6.  Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis.

Authors:  Jutta Marfurt; Abed Nasereddin; Igor Niederwieser; Charles L Jaffe; Hans-Peter Beck; Ingrid Felger
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Differences in transmission seasons as an epidemiological tool for characterization of anthroponotic and zoonotic cutaneous leishmaniasis in northern Afghanistan.

Authors:  Michael Faulde; Joachim Schrader; Gerhard Heyl; Mohammed Amirih
Journal:  Acta Trop       Date:  2007-11-09       Impact factor: 3.112

8.  Zoonotic cutaneous leishmaniasis outbreak in Mazar-e Sharif, northern Afghanistan: an epidemiological evaluation.

Authors:  Michael Faulde; Joachim Schrader; Gerhard Heyl; Mohammed Amirih; Achim Hoerauf
Journal:  Int J Med Microbiol       Date:  2007-09-20       Impact factor: 3.473

Review 9.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Urbà González; Mariona Pinart; Ludovic Reveiz; Jorge Alvar
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

10.  Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan.

Authors:  Richard Reithinger; Mohammad Mohsen; Khoksar Aadil; Majeed Sidiqi; Panna Erasmus; Paul G Coleman
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more
  21 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

2.  Variation in clinical presentation and genotype of causative Leishmania major strain in cutaneous leishmaniasis in north and south Afghanistan.

Authors:  Pieter-Paul A M van Thiel; Tom van Gool; William R Faber; Tjalling Leenstra; Piet A Kager; Aldert Bart
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 3.  Social and Economic Burden of Human Leishmaniasis.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Am J Trop Med Hyg       Date:  2016-01-19       Impact factor: 2.345

Review 4.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

5.  A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major.

Authors:  Delbert S Abi Abdallah; Alan Pavinski Bitar; Fabiano Oliveira; Claudio Meneses; Justin J Park; Susana Mendez; Shaden Kamhawi; Jesus G Valenzuela; Hélène Marquis
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

6.  Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan.

Authors:  Marie Plourde; Adriano Coelho; Yoav Keynan; Oscar E Larios; Momar Ndao; Annie Ruest; Gaétan Roy; Ethan Rubinstein; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

7.  Protective immunity and vaccination against cutaneous leishmaniasis.

Authors:  Ifeoma Okwor; Zhirong Mou; Dong Liu; Jude Uzonna
Journal:  Front Immunol       Date:  2012-05-29       Impact factor: 7.561

8.  Outbreak of Cutaneous Leishmaniasis in Peruvian Military Personnel Undertaking Training Activities in the Amazon Basin, 2010.

Authors:  Marianela Oré; Eliana Sáenz; Rufino Cabrera; Juan F Sanchez; Maxy B De Los Santos; Carmen M Lucas; Jorge H Núñez; Kimberly A Edgel; Justino Sopan; Jorge Fernández; Andres M Carnero; G Christian Baldeviano; Juan C Arrasco; Paul C F Graf; Andres G Lescano
Journal:  Am J Trop Med Hyg       Date:  2015-06-15       Impact factor: 2.345

Review 9.  Cutaneous leishmaniasis: recent developments in diagnosis and management.

Authors:  Henry J C de Vries; Sophia H Reedijk; Henk D F H Schallig
Journal:  Am J Clin Dermatol       Date:  2015-04       Impact factor: 7.403

10.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.